{"brief_title": "A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)", "brief_summary": "To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.", "condition": ["Glaucoma, Open-Angle", "Ocular Hypertension"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Travoprost (0.004%)", "Latanoprost (0.005%)/Timolol (0.5%)"], "criteria": "Patients of any race and either sex with open-angle glaucoma (with or without pigment dispersion or pseudoexfoliation component) or ocular hypertension.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "OHT", "mesh_term": ["Hypertension", "Glaucoma", "Glaucoma, Open-Angle", "Ocular Hypertension", "Latanoprost", "Travoprost", "Timolol"], "id": "NCT00051155"}